About this trial
The introduction of synthetic opioids in 1960 to general anesthesia together with sedative hypnotics and muscle relaxants allowed the appearance of the concept of multimodal balanced anesthesia. Although they help in achieving hemodynamic stability during anesthesia of open heart surgeries, their administration consequences are neither scarce nor benign to the patient. Perioperative opioids are associated with increased incidence of respiratory depression, prolonged mechanical ventilation, nausea and vomiting, prolonged sedation, Postoperative ileus (POI), urine retention, Postoperative cognitive dysfunction (POCD), immune depression and hyperalgesia (Beloeil et al., 2018).
Coronary artery bypass graft surgery with cardiopulmonary bypass (CPB) is particularly vulnerable to the above-mentioned complications. Indeed, some of the side effects of this surgery overlap with the adverse effects of opioids. Postoperative pulmonary complications are observed in up to 50% of patients (Fisscher et al., 2022) and POCD or delirium in 4-54% according to studies (Bhushan et al., 2021). Whereas major gastrointestinal complications are estimated to occur in around 3% of patients, essentially acute pancreatitis, postoperative ileus (Marsoner et al., 2019).
Opioid-free anesthesia (OFA) strategies have emerged to avoid intraoperative opioid use. It is based on the fact that a sympathetic reaction evidenced by hemodynamic changes in an anesthetised patient does not systematically reflect pain. In addition, a sleeping patient will not recall pain, while hormonal stress and sympathetic and inflammatory reactions can be controlled by therapeutic classes
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age group: above 65 years old of both sex. Undergoing an elective coronary artery bypass graft surgeries with cardiopulmonary bypass.
Disqualifiers
Past or ongoing history of drug abuse.
Psychiatric disease and cognitive disorders.
Inability to perform the confusion assessment method for the intensive care unit (CAM-ICU) test.
EF<40 %.
Trial design
Parallel
Treatments tested in this trial
Opioid free anesthesia
Druggroup (F) receive dexmedetomidine and ketamine
Opioid based Anesthesia
DrugOpioid based group receive fentanyl
Treatment groups
Trial outcomes
Primary outcomes
Enhanced recovery time
From transfer the patient to icu till extubation
Enhanced recovery defined as time of extubation
Time from extubation after transfer to icu
Secondary outcomes
POCD
Post operative delerium by cam score which has 4 features ....to diagnose delerium patient must have 3 features
Post operative opioid consumption
Total morphine consumption
Cortisol level
cortisol level
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: